GLP-1 drugs enter psychiatry, curbing antipsychotic weight gain while raising new questions about addiction, mood, eating disorders, and culture.
Ravleen Kaur Suri, MD
Advertisement
Dr Suri is a psychiatry resident year 2 at BronxCare Health System in New York City, with interests in lifestyle psychiatry, preventive mental health, and evidence-based wellness interventions.
Articles by Ravleen Kaur Suri, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Ozempic Dilemma: Promises and Pitfalls in Psychiatry
2
ALKS 7290 for Adjunctive Treatment for MDD Enters Phase 2 Study
3
Why Generic Antidepressant Cycling Falls Short: Early Augmentation and TD Risk
4
Brain Trust: Bessel van der Kolk, MD, on Complex PTSD, Attachment, and the Limits of Pharmacotherapy
5